Tuesday, August 01, 2017 8:10:39 AM
July 31, 2017 4:05 PM EDT
Cantor Fitzgerald initiates coverage on Neos Therapeutics (NASDAQ: NEOS) with a Overweight rating and a price target of $20.00.
https://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Starts+Neos+Therapeutics+(NEOS)+at+Overweight/13148515.html
NEOS
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM